I have APOE4 -- how serious is that, and what can I do about it?

The APOE4 gene is the best-known genetic risk factor for the most common form of Alzheimer's disease that begins in later life. Even one copy of APOE4 (heterozygous) considerably raises the risk of this disease: in families with late-onset Alzheimer's, the risk increased substantially and the average age at which the disease began decreased. Two copies (homozygous) are even more consequential: the risk rises to approximately 90% before age 80, with an average age of onset of 68 years. In the families studied, carrying two copies was nearly sufficient to develop the disease before the age of eighty. That is serious, but it does not mean that an Alzheimer's diagnosis is a certainty, especially not with one copy.

APOE4 acts through multiple biological pathways simultaneously. It disrupts the clearance of amyloid-beta (a harmful protein that accumulates in the brain), promotes the buildup of tau proteins, causes oxidative stress, impairs cholesterol transport in the brain, damages blood vessels and mitochondria (the energy powerhouses of cells), and even disrupts sleep. Researchers emphasise that this damage begins twenty years before the first symptoms appear, which in theory makes early detection possible. The precise molecular mechanisms, however, have not yet been fully elucidated. In addition, APOE4 also raises the risk of cardiovascular disease and stroke, although this varies by sex and ethnicity.

Important news for people with APOE4: manageable lifestyle factors carry considerable weight, sometimes even more than the gene itself. High blood pressure or diabetes diagnosed before age 62 conferred a greater Alzheimer's risk in a large British cohort study (UKBiobank, more than 5,600 participants) than carrying APOE4 alone. Obesity before age 62 increased the risk by 54%, and between ages 62 and 72 the risk nearly tripled. Only after age 72 did APOE4 become the dominant risk factor. This means that intervening early on blood pressure, blood sugar, and weight can make a concrete difference.

In the area of nutrition, there is an initial indication that the Mediterranean diet influences dementia-related markers in the blood more favourably in people with two copies of APOE4 than in non-carriers. This prospective cohort study (Harvard) suggests that diet may be particularly relevant for APOE4 carriers. Evidence that it actually prevents dementia, however, is still lacking. A widely discussed idea -- namely that a stomach bacterium (Helicobacter pylori) might increase the risk in APOE4 carriers -- was not confirmed in a large Norwegian cohort study.

What can you do in practice? Based on the available evidence: keep blood pressure, blood sugar, and weight under control as early as possible, because those factors matter more than your genotype at younger ages. A Mediterranean dietary pattern appears to be particularly worthwhile for APOE4 carriers. New diagnostic techniques and artificial intelligence can identify high-risk groups at an early stage, but concrete preventive medications or therapies specifically for APOE4 carriers are still in development. Discuss your situation with a doctor or genetic counsellor so that monitoring and lifestyle adjustments can be tailored to your personal circumstances.